Article info
PDFEditorial
Dronedarone for the treatment of non-permanent atrial fibrillation: National Institute for Health and Clinical Excellence guidance
- Correspondence to Dr A John Camm, Department of Clinical Cardiology, Cardiac and Vascular Sciences, St. George's University of London, Cranmer Terrace, London SW17 0RE, UK; jcamm{at}sgul.ac.uk
Citation
Dronedarone for the treatment of non-permanent atrial fibrillation: National Institute for Health and Clinical Excellence guidance
Publication history
- First published April 30, 2013.
Online issue publication
March 15, 2016
Article Versions
- Previous version (15 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions